Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis.
Marina Rode von EssenRikke Holm Holm HansenCamilla HøjgaardCecilie AmmitzbøllHeinz WiendlFinn SellebjergPublished in: Neurology(R) neuroimmunology & neuroinflammation (2022)
T cells, increases effector T cell control, and decreases T cell autoreactivity.